US Stock MarketDetailed Quotes

ZBIO Zenas BioPharma

Watchlist
  • 6.780
  • -0.710-9.48%
Close Apr 10 16:00 ET
283.40MMarket Cap-1.81P/E (TTM)

About Zenas BioPharma Company

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

Company Profile

SymbolZBIO
Company NameZenas BioPharma
Listing DateSep 13, 2024
Issue Price17.00
Founded2019
CEOMr. Leon O. Moulder, Jr
MarketNASDAQ
Employees130
Fiscal Year Ends12-31
Address852 Winter Street,Suite 250
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Websitehttps://www.zenasbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Leon O. Moulder, Jr
  • Chief Executive Officer and Chairman of the Board
  • 2.60M
  • Orlando Oliveira
  • Chief Commercial Officer
  • --
  • Joseph Farmer
  • President and Chief Operating Officer
  • 1.29M
  • Jennifer A. Fox
  • Principal Accounting Officer, Chief Business Officer and Chief Financial Officer
  • 2.57M
  • Patricia L. Allen
  • Independent Director
  • --
  • Tomas Kiselak
  • Independent Director
  • --
  • Ting Xiao
  • Independent Director
  • --
  • Patrick G. Enright, M.B.A.
  • Independent Director
  • --
  • James P. Boylan, M.B.A.
  • Independent Director
  • --
  • Jake R. Num
  • Independent Director
  • --
  • Dr. John J. Orloff, M.D.
  • Independent Director
  • --
  • Dr. Hongbo Lu, PhD
  • Independent Director
  • --

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 11.000
Sample Name
Sample Code
 62.470
Sample Name
Sample Code
 184.750
4
DexCom
DXCM
67.300
5
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.280
Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 8.900
Sample Name
Sample Code
 381.350
Sample Name
Sample Code
 117.870
4
Toll Brothers
TOL
92.740
5
Alphabet-C
GOOG
155.370
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 104.180
Sample Name
Sample Code
 381.350
Sample Name
Sample Code
 921.170
4
Cisco
CSCO
56.590
5
Alphabet-C
GOOG
155.370
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 8.168
Sample Name
Sample Code
 1.780
Sample Name
Sample Code
 8.570
4
Bit Origin
BTOG
0.1500
5
Argo Blockchain
ARBK
0.3244
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -